Abstract

Right ventricular (RV) failure is a known and dreaded complication associated with left ventricular assist device (LVAD) implantation. It occurs in 9% to 42% of patients1 and confers an increased risk of morbidity and mortality after LVAD implantation.2 RV failure after LVAD implantation is associated with a 3-fold increase in mortality risk at 6 months. And 1-year survival drops to below 50% once biventricular support is required.1 Thus, identifying LVAD patients who may need RV support, determining when to initiate RV support, and choosing the most suitable temporary mechanical circulatory support (MCS) device are all vitally important.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.